F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
Elections
Archived
•
July 24, 2026
•
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
Source: https://rss.nytimes.com/services/xml/rss/nyt/Politics.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



